{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T02:55:56Z","timestamp":1789181756951,"version":"build-2803163510"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100018647","name":"RUDN University","doi-asserted-by":"publisher","award":["212202-2-000"],"award-info":[{"award-number":["212202-2-000"]}],"id":[{"id":"10.13039\/501100018647","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s11060-025-05070-5","type":"journal-article","created":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T07:28:30Z","timestamp":1747380510000},"page":"401-409","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Long-term neurocognitive sequelae in pediatric medulloblastoma survivors treated according to the HIT protocol"],"prefix":"10.1007","volume":"174","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-3133-3283","authenticated-orcid":false,"given":"Iuliia A.","family":"Aldeeva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3553-1234","authenticated-orcid":false,"given":"Elena V.","family":"Glebova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9142-5375","authenticated-orcid":false,"given":"Roza A.","family":"Sarkisyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8568-0118","authenticated-orcid":false,"given":"Elizaveta N.","family":"Romanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4546-6926","authenticated-orcid":false,"given":"Nadezhda M.","family":"Karpova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0966-6452","authenticated-orcid":false,"given":"Valeriia G.","family":"Shapovalova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6383-2822","authenticated-orcid":false,"given":"Alexander F.","family":"Karelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,16]]},"reference":[{"key":"5070_CR1","volume-title":"Medulloblastoma","author":"S Mahapatra","year":"2025","unstructured":"Mahapatra S, Amsbaugh MJ (2025) Medulloblastoma. In: StatPearls. StatPearls Publishing, Treasure Island (FL)"},{"key":"5070_CR2","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1007\/s00381-015-2867-3","volume":"31","author":"E Hanzlik","year":"2015","unstructured":"Hanzlik E, Woodrome SE, Abdel-Baki M et al (2015) A systematic review of neuropsychological outcomes following posterior fossa tumor surgery in children. Childs Nerv Syst 31:1869\u20131875. https:\/\/doi.org\/10.1007\/s00381-015-2867-3","journal-title":"Childs Nerv Syst"},{"key":"5070_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.pediatrneurol.2010.07.004","volume":"44","author":"J-MG Saury","year":"2011","unstructured":"Saury J-MG, Emanuelson I (2011) Cognitive consequences of the treatment of Medulloblastoma among children. Pediatr Neurol 44:21\u201330. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2010.07.004","journal-title":"Pediatr Neurol"},{"key":"5070_CR4","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1007\/978-3-030-23810-0_77","volume-title":"Handbook of the cerebellum and cerebellar disorders","author":"JD Schmahmann","year":"2022","unstructured":"Schmahmann JD (2022) The cerebellar cognitive affective syndrome and the neuropsychiatry of the cerebellum. In: Manto MU, Gruol DL, Schmahmann JD et al (eds) Handbook of the cerebellum and cerebellar disorders. Springer International Publishing, Cham, pp 1955\u20131993"},{"key":"5070_CR5","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1093\/neuonc\/nox135","volume":"19","author":"JE Schreiber","year":"2017","unstructured":"Schreiber JE, Palmer SL, Conklin HM et al (2017) Posterior fossa syndrome and long-term neuropsychological outcomes among children treated for Medulloblastoma on a multi-institutional, prospective study. Neuro-Oncol 19:1673\u20131682. https:\/\/doi.org\/10.1093\/neuonc\/nox135","journal-title":"Neuro-Oncol"},{"key":"5070_CR6","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1200\/JCO.2001.19.8.2302","volume":"19","author":"SL Palmer","year":"2001","unstructured":"Palmer SL, Goloubeva O, Reddick WE et al (2001) Patterns of intellectual development among survivors of pediatric Medulloblastoma: A longitudinal analysis. J Clin Oncol 19:2302\u20132308. https:\/\/doi.org\/10.1200\/JCO.2001.19.8.2302","journal-title":"J Clin Oncol"},{"key":"5070_CR7","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s10143-023-02080-7","volume":"46","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Wu Y, Zhao X et al (2023) The insertion and management of an external ventricular drain in pediatric patients with hydrocephalus associated with Medulloblastoma. Neurosurg Rev 46:170. https:\/\/doi.org\/10.1007\/s10143-023-02080-7","journal-title":"Neurosurg Rev"},{"key":"5070_CR8","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s11060-012-0816-5","volume":"108","author":"S Pietil\u00e4","year":"2012","unstructured":"Pietil\u00e4 S, Korpela R, Lenko HL et al (2012) Neurological outcome of childhood brain tumor survivors. J Neurooncol 108:153\u2013161. https:\/\/doi.org\/10.1007\/s11060-012-0816-5","journal-title":"J Neurooncol"},{"key":"5070_CR9","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/mpo.10211","volume":"40","author":"TS Reimers","year":"2003","unstructured":"Reimers TS, Ehrenfels S, Mortensen EL et al (2003) Cognitive deficits in long-term survivors of childhood brain tumors: identification of predictive factors. Med Pediatr Oncol 40:26\u201334. https:\/\/doi.org\/10.1002\/mpo.10211","journal-title":"Med Pediatr Oncol"},{"key":"5070_CR10","doi-asserted-by":"publisher","first-page":"28","DOI":"10.14791\/btrt.2022.0046","volume":"11","author":"JY Choi","year":"2023","unstructured":"Choi JY (2023) Medulloblastoma: current perspectives and recent advances. Brain Tumor Res Treat 11:28. https:\/\/doi.org\/10.14791\/btrt.2022.0046","journal-title":"Brain Tumor Res Treat"},{"key":"5070_CR11","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.2174\/1570159X15666171129111324","volume":"16","author":"S Khatua","year":"2018","unstructured":"Khatua S, Song A, Sridhar DC, Mack SC (2018) Childhood Medulloblastoma: current therapies, emerging molecular landscape and newer therapeutic insights. Curr Neuropharmacol 16:1045\u20131058. https:\/\/doi.org\/10.2174\/1570159X15666171129111324","journal-title":"Curr Neuropharmacol"},{"key":"5070_CR12","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/S1470-2045(06)70867-1","volume":"7","author":"A Gajjar","year":"2006","unstructured":"Gajjar A, Chintagumpala M, Ashley D et al (2006) Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed Medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial. Lancet Oncol 7:813\u2013820. https:\/\/doi.org\/10.1016\/S1470-2045(06)70867-1","journal-title":"Lancet Oncol"},{"key":"5070_CR13","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/978-3-319-47489-2_6","volume-title":"Research in clinical pragmatics","author":"K Docking","year":"2017","unstructured":"Docking K, Paquier P, Morgan A (2017) Childhood brain tumour. In: Cummings L (ed) Research in clinical pragmatics. Springer International Publishing, Cham, pp 131\u2013164"},{"key":"5070_CR14","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00401-014-1276-0","volume":"128","author":"T Pietsch","year":"2014","unstructured":"Pietsch T, Schmidt R, Remke M et al (2014) Prognostic significance of clinical, histopathological, and molecular characteristics of Medulloblastomas in the prospective HIT2000 multicenter clinical trial cohort. Acta Neuropathol (Berl) 128:137\u2013149. https:\/\/doi.org\/10.1007\/s00401-014-1276-0","journal-title":"Acta Neuropathol (Berl)"},{"key":"5070_CR15","doi-asserted-by":"publisher","first-page":"e28395","DOI":"10.1002\/pbc.28395","volume":"68","author":"S Baliga","year":"2021","unstructured":"Baliga S, Gandola L, Timmermann B et al (2021) Brain tumors: Medulloblastoma, ATRT, ependymoma. Pediatr Blood Cancer 68:e28395. https:\/\/doi.org\/10.1002\/pbc.28395","journal-title":"Pediatr Blood Cancer"},{"key":"5070_CR16","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.neuchi.2018.03.002","volume":"67","author":"E De Doger","year":"2021","unstructured":"De Doger E, Kieffer V, Dufour C et al (2021) Neuropsychological consequences of childhood Medulloblastoma and possible interventions: A review. Neurochirurgie 67:90\u201398. https:\/\/doi.org\/10.1016\/j.neuchi.2018.03.002","journal-title":"Neurochirurgie"},{"key":"5070_CR17","doi-asserted-by":"publisher","first-page":"118071","DOI":"10.1016\/j.lfs.2020.118071","volume":"258","author":"NM Mounier","year":"2020","unstructured":"Mounier NM, Abdel-Maged AE-S, Wahdan SA et al (2020) Chemotherapy-induced cognitive impairment (CICI): an overview of etiology and pathogenesis. Life Sci 258:118071. https:\/\/doi.org\/10.1016\/j.lfs.2020.118071","journal-title":"Life Sci"},{"key":"5070_CR18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.spen.2012.02.014","volume":"19","author":"NJ Ullrich","year":"2012","unstructured":"Ullrich NJ, Embry L (2012) Neurocognitive dysfunction in survivors of childhood brain tumors. Semin Pediatr Neurol 19:35\u201342. https:\/\/doi.org\/10.1016\/j.spen.2012.02.014","journal-title":"Semin Pediatr Neurol"},{"key":"5070_CR19","unstructured":"Ole Juhnke B, Mynarek M, von Hoff K et al (2017) HIT-MED guidance for patients with newly diagnosed Medulloblastoma ependymoma CNS embryonal tumour and Pineoblastoma. Version 40\u2013\u200902"},{"key":"5070_CR20","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1093\/neuonc\/nox062","volume":"19","author":"JO Glass","year":"2017","unstructured":"Glass JO, Ogg RJ, Hyun JW et al (2017) Disrupted development and integrity of frontal white matter in patients treated for pediatric Medulloblastoma. Neuro-Oncol 19:1408\u20131418. https:\/\/doi.org\/10.1093\/neuonc\/nox062","journal-title":"Neuro-Oncol"},{"key":"5070_CR21","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1200\/JCO.2004.05.186","volume":"22","author":"BJ Spiegler","year":"2004","unstructured":"Spiegler BJ, Bouffet E, Greenberg ML et al (2004) Change in neurocognitive functioning after treatment with cranial radiation in childhood. J Clin Oncol 22:706\u2013713. https:\/\/doi.org\/10.1200\/JCO.2004.05.186","journal-title":"J Clin Oncol"},{"key":"5070_CR22","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.ijrobp.2004.03.027","volume":"60","author":"RI Jakacki","year":"2004","unstructured":"Jakacki RI, Feldman H, Jamison C et al (2004) A pilot study of preirradiation chemotherapy and 1800\u00a0cgy craniospinal irradiation in young children with Medulloblastoma. Int J Radiat Oncol 60:531\u2013536. https:\/\/doi.org\/10.1016\/j.ijrobp.2004.03.027","journal-title":"Int J Radiat Oncol"},{"key":"5070_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006678.pub2","author":"EM Michiels","year":"2015","unstructured":"Michiels EM, Schouten-Van Meeteren AY, Doz F et al (2015) Chemotherapy for children with Medulloblastoma. Cochrane Database Syst Rev 2015. https:\/\/doi.org\/10.1002\/14651858.CD006678.pub2","journal-title":"Cochrane Database Syst Rev 2015"},{"key":"5070_CR24","doi-asserted-by":"publisher","first-page":"3470","DOI":"10.1200\/JCO.2001.19.15.3470","volume":"19","author":"MD Ris","year":"2001","unstructured":"Ris MD, Packer R, Goldwein J et al (2001) Intellectual outcome after Reduced-Dose radiation therapy plus adjuvant chemotherapy for Medulloblastoma: A children\u2019s Cancer group study. J Clin Oncol 19:3470\u20133476. https:\/\/doi.org\/10.1200\/JCO.2001.19.15.3470","journal-title":"J Clin Oncol"},{"key":"5070_CR25","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.3390\/cancers14092285","volume":"14","author":"FY Fang","year":"2022","unstructured":"Fang FY, Rosenblum JS, Ho WS, Heiss JD (2022) New developments in the pathogenesis, therapeutic targeting, and treatment of pediatric Medulloblastoma. Cancers 14:2285. https:\/\/doi.org\/10.3390\/cancers14092285","journal-title":"Cancers"},{"key":"5070_CR26","doi-asserted-by":"publisher","first-page":"5945","DOI":"10.3390\/cancers13235945","volume":"13","author":"C Seidel","year":"2021","unstructured":"Seidel C, Heider S, Hau P et al (2021) Radiotherapy in Medulloblastoma\u2014Evolution of treatment, current concepts and future perspectives. Cancers 13:5945. https:\/\/doi.org\/10.3390\/cancers13235945","journal-title":"Cancers"},{"key":"5070_CR27","doi-asserted-by":"publisher","first-page":"5511","DOI":"10.1200\/JCO.2005.00.703","volume":"23","author":"RK Mulhern","year":"2005","unstructured":"Mulhern RK, Palmer SL, Merchant TE et al (2005) Neurocognitive consequences of Risk-Adapted therapy for childhood Medulloblastoma. J Clin Oncol 23:5511\u20135519. https:\/\/doi.org\/10.1200\/JCO.2005.00.703","journal-title":"J Clin Oncol"},{"key":"5070_CR28","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/S1474-4422(07)70289-2","volume":"6","author":"JR Crawford","year":"2007","unstructured":"Crawford JR, MacDonald TJ, Packer RJ (2007) Medulloblastoma in childhood: new biological advances. Lancet Neurol 6:1073\u20131085. https:\/\/doi.org\/10.1016\/S1474-4422(07)70289-2","journal-title":"Lancet Neurol"},{"key":"5070_CR29","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ctrv.2008.09.002","volume":"35","author":"P Fossati","year":"2009","unstructured":"Fossati P, Ricardi U, Orecchia R (2009) Pediatric Medulloblastoma: toxicity of current treatment and potential role of protontherapy. Cancer Treat Rev 35:79\u201396. https:\/\/doi.org\/10.1016\/j.ctrv.2008.09.002","journal-title":"Cancer Treat Rev"},{"key":"5070_CR30","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1017\/S135561771300129X","volume":"20","author":"L Riggs","year":"2014","unstructured":"Riggs L, Bouffet E, Laughlin S et al (2014) Changes to memory structures in children treated for posterior Fossa tumors. J Int Neuropsychol Soc 20:168\u2013180. https:\/\/doi.org\/10.1017\/S135561771300129X","journal-title":"J Int Neuropsychol Soc"},{"key":"5070_CR31","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-16-1907-6","volume-title":"L.S. Vygotsky\u2019s pedological works. Volume 2.: the problem of age","author":"LS Vygotsky","year":"2021","unstructured":"Vygotsky LS (2021) L.S. Vygotsky\u2019s pedological works. Volume 2.: the problem of age. Springer Singapore, Singapore"},{"key":"5070_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-025-04945-x","author":"J-Y Huang","year":"2025","unstructured":"Huang J-Y, Yeh T-C, Liu H-C et al (2025) Computerized assessment of neuropsychological functioning in pediatric brain tumor patients. J Neurooncol. https:\/\/doi.org\/10.1007\/s11060-025-04945-x","journal-title":"J Neurooncol"},{"key":"5070_CR33","first-page":"91","volume":"49","author":"B Do\u011fan","year":"2009","unstructured":"Do\u011fan B (2009) Multiple-choice reaction and visual perception in female and male elite athletes. J Sports Med Phys Fit 49:91\u201396","journal-title":"J Sports Med Phys Fit"},{"key":"5070_CR34","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1093\/nop\/npaa039","volume":"8","author":"M Alemany","year":"2021","unstructured":"Alemany M, Velasco R, Sim\u00f3 M, Bruna J (2021) Late effects of cancer treatment: consequences for long-term brain cancer survivors. Neuro-Oncol Pract 8:18\u201330. https:\/\/doi.org\/10.1093\/nop\/npaa039","journal-title":"Neuro-Oncol Pract"},{"key":"5070_CR35","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ejpn.2009.10.005","volume":"14","author":"PK Duffner","year":"2010","unstructured":"Duffner PK (2010) Risk factors for cognitive decline in children treated for brain tumors. Eur J Paediatr Neurol 14:106\u2013115. https:\/\/doi.org\/10.1016\/j.ejpn.2009.10.005","journal-title":"Eur J Paediatr Neurol"},{"key":"5070_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09297049.2017.1380178","volume":"25","author":"TZ King","year":"2019","unstructured":"King TZ, Ailion AS, Fox ME, Hufstetler SM (2019) Neurodevelopmental model of long-term outcomes of adult survivors of childhood brain tumors. Child Neuropsychol 25:1\u201321. https:\/\/doi.org\/10.1080\/09297049.2017.1380178","journal-title":"Child Neuropsychol"},{"key":"5070_CR37","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/ddrr.32","volume":"14","author":"SL Palmer","year":"2008","unstructured":"Palmer SL (2008) Neurodevelopmental impact on children treated for Medulloblastoma: A review and proposed conceptual model. Dev Disabil Res Rev 14:203\u2013210. https:\/\/doi.org\/10.1002\/ddrr.32","journal-title":"Dev Disabil Res Rev"},{"key":"5070_CR38","doi-asserted-by":"publisher","unstructured":"Eckert MA (2011) Slowing down: Age-Related Neurobiological predictors of processing speed. https:\/\/doi.org\/10.3389\/fnins.2011.00025. Front Neurosci 5:","DOI":"10.3389\/fnins.2011.00025"},{"key":"5070_CR39","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4684-7741-2","volume-title":"Higher cortical functions in man","author":"AR Luria","year":"1995","unstructured":"Luria AR (1995) Higher cortical functions in man. Springer US, Boston, MA"},{"key":"5070_CR40","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s41386-021-01152-w","volume":"47","author":"V Menon","year":"2022","unstructured":"Menon V, D\u2019Esposito M (2022) The role of PFC networks in cognitive control and executive function. Neuropsychopharmacology 47:90\u2013103. https:\/\/doi.org\/10.1038\/s41386-021-01152-w","journal-title":"Neuropsychopharmacology"},{"key":"5070_CR41","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cortex.2011.07.001","volume":"48","author":"S Budisavljevic","year":"2012","unstructured":"Budisavljevic S, Ramnani N (2012) Cognitive deficits from a cerebellar tumour: A historical case report from Luria\u2019s laboratory. Cortex 48:26\u201335. https:\/\/doi.org\/10.1016\/j.cortex.2011.07.001","journal-title":"Cortex"},{"key":"5070_CR42","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1007\/s12311-011-0272-3","volume":"11","author":"N Ramnani","year":"2012","unstructured":"Ramnani N (2012) Frontal lobe and posterior parietal contributions to the Cortico-cerebellar system. Cerebellum 11:366\u2013383. https:\/\/doi.org\/10.1007\/s12311-011-0272-3","journal-title":"Cerebellum"},{"key":"5070_CR43","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/pbc.21223","volume":"50","author":"M Bri\u00e8re","year":"2008","unstructured":"Bri\u00e8re M, Scott JG, McNall-Knapp RY, Adams RL (2008) Cognitive outcome in pediatric brain tumor survivors: delayed attention deficit at long\u2010term follow\u2010up. Pediatr Blood Cancer 50:337\u2013340. https:\/\/doi.org\/10.1002\/pbc.21223","journal-title":"Pediatr Blood Cancer"},{"key":"5070_CR44","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/(sici)1096-911x(1998)30:1+<25::aid-mpo4>3.0.co;2-a","volume":"1","author":"M Dennis","year":"1998","unstructured":"Dennis M, Hetherington CR, Spiegler BJ (1998) Memory and attention after childhood brain tumors. Med Pediatr Oncol Suppl 1:25\u201333. https:\/\/doi.org\/10.1002\/(sici)1096-911x(1998)30:1+%3C25::aid-mpo4%3E3.0.co;2-a","journal-title":"Med Pediatr Oncol Suppl"},{"key":"5070_CR45","doi-asserted-by":"publisher","first-page":"3494","DOI":"10.1200\/JCO.2012.47.4775","volume":"31","author":"SL Palmer","year":"2013","unstructured":"Palmer SL, Armstrong C, Onar-Thomas A et al (2013) Processing speed, attention, and working memory after treatment for Medulloblastoma: an international, prospective, and longitudinal study. J Clin Oncol 31:3494\u20133500. https:\/\/doi.org\/10.1200\/JCO.2012.47.4775","journal-title":"J Clin Oncol"},{"key":"5070_CR46","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1093\/neuonc\/nor015","volume":"13","author":"K Edelstein","year":"2011","unstructured":"Edelstein K, Spiegler BJ, Fung S et al (2011) Early aging in adult survivors of childhood Medulloblastoma: long-term neurocognitive, functional, and physical outcomes. Neuro-Oncol 13:536\u2013545. https:\/\/doi.org\/10.1093\/neuonc\/nor015","journal-title":"Neuro-Oncol"},{"key":"5070_CR47","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ejpn.2015.11.001","volume":"20","author":"E Koustenis","year":"2016","unstructured":"Koustenis E, Hern\u00e1iz Driever P, De Sonneville L, Rueckriegel SM (2016) Executive function deficits in pediatric cerebellar tumor survivors. Eur J Paediatr Neurol 20:25\u201337. https:\/\/doi.org\/10.1016\/j.ejpn.2015.11.001","journal-title":"Eur J Paediatr Neurol"},{"key":"5070_CR48","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S1470-2045(04)01507-4","volume":"5","author":"RK Mulhern","year":"2004","unstructured":"Mulhern RK, Merchant TE, Gajjar A et al (2004) Late neurocognitive sequelae in survivors of brain tumours in childhood. Lancet Oncol 5:399\u2013408. https:\/\/doi.org\/10.1016\/S1470-2045(04)01507-4","journal-title":"Lancet Oncol"},{"key":"5070_CR49","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.3390\/cancers14061540","volume":"14","author":"I Alessi","year":"2022","unstructured":"Alessi I, Caroleo AM, De Palma L et al (2022) Short and Long-Term toxicity in pediatric Cancer treatment: central nervous system damage. Cancers 14:1540. https:\/\/doi.org\/10.3390\/cancers14061540","journal-title":"Cancers"},{"key":"5070_CR50","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1037\/0894-4105.22.2.159","volume":"22","author":"DJ Mabbott","year":"2008","unstructured":"Mabbott DJ, Penkman L, Witol A et al (2008) Core neurocognitive functions in children treated for posterior fossa tumors. Neuropsychology 22:159\u2013168. https:\/\/doi.org\/10.1037\/0894-4105.22.2.159","journal-title":"Neuropsychology"},{"key":"5070_CR51","doi-asserted-by":"publisher","first-page":"0","DOI":"10.21608\/aps.2023.243591.1140","volume":"0","author":"N Sabry","year":"2023","unstructured":"Sabry N, Michel H, Menze E (2023) Chemotherapy and cognitive function: comprehensive review on methotrexate-induced chemobrain. Arch Pharm Sci Ain Shams Univ 0:0\u20130. https:\/\/doi.org\/10.21608\/aps.2023.243591.1140","journal-title":"Arch Pharm Sci Ain Shams Univ"},{"key":"5070_CR52","doi-asserted-by":"publisher","first-page":"108939","DOI":"10.1016\/j.neuropharm.2021.108939","volume":"206","author":"J Wen","year":"2022","unstructured":"Wen J, Patel C, Diglio F et al (2022) Cognitive impairment persists at least 1 year after juvenile rats are treated with methotrexate. Neuropharmacology 206:108939. https:\/\/doi.org\/10.1016\/j.neuropharm.2021.108939","journal-title":"Neuropharmacology"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05070-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-025-05070-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05070-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T11:55:28Z","timestamp":1751284528000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-025-05070-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,16]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["5070"],"URL":"https:\/\/doi.org\/10.1007\/s11060-025-05070-5","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,16]]},"assertion":[{"value":"3 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology (protocol number 8\/2017 of 24.10.2017). Information about the trial was provided to participants and their parents\/legal representatives. Written informed consent was obtained from all participants or their parents\/legal representatives.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This study suggests that pediatric medulloblastoma patients treated with the HIT protocol experience cognitive decline that worsens after the completion of active treatment. Longer duration of remission is associated with poorer scores on cognitive tests which underscores the importance of continuous monitoring and targeted rehabilitative interventions for medulloblastoma survivors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Pr\u00e9cis"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}